The trade off between giving access to medicine that clearly helps and testing its effect carefully isn't done very well if you stop early with only a minor eff

The trade off between giving access to medicine that clearly helps and testing its effect carefully isn't done very well if you stop early with only a minor effect size. As at that point you're more than likely to just be giving people access to medicine that is far from clearly helping and possibly not even vaguely effective.